drugset / Trial / NCT04816123
The Mass Balance and Biotransformation of [14C]Donafenib in Healthy Adult Man
NaSingle-groupOpen-labelOther
Summary
This study was designed to evaluate the mass balance and biotransformation after single-dose of \[14C\]Donafenib orally in Chinese healthy adult male volunteers, revealing the overall pharmacokinetic characteristics of Donafenib in humans, and providing a reference for the rational administration.
Timeline
- Start
- 2018-10-09
- Primary completion
- 2018-12-18
- Completion
- 2018-12-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Donafenib | Small molecule | 300 mg | Oral |
Indications
No indication recorded.